DaVita
DVA
#2026
Rank
HK$78.74 B
Marketcap
HK$1,178
Share price
2.30%
Change (1 day)
3.82%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

Revenue for DaVita (DVA)

Revenue in 2024: HK$99.49 Billion

According to DaVita's latest financial reports the company's current revenue (TTM ) is HK$104.07 Billion. In 2024 the company made a revenue of HK$99.49 Billion an increase over the revenue in the year 2023 that were of HK$94.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DaVita from 1996 to 2024

Annual revenue

Year Revenue Change
2024HK$99.49 B4.93%
2023HK$94.81 B4.52%
2022HK$90.71 B0.12%
2021HK$90.59 B1.18%
2020HK$89.54 B0.96%
2019HK$88.69 B-0.69%
2018HK$89.31 B5.1%
2017HK$84.97 B-20.18%
2016HK$106.46 B-0.34%
2015HK$106.81 B7.63%
2014HK$99.24 B8.79%
2013HK$91.22 B44.66%
2012HK$63.05 B18.63%
2011HK$53.15 B5.97%
2010HK$50.15 B5.9%
2009HK$47.36 B8.29%
2008HK$43.73 B6.56%
2007HK$41.04 B8.13%
2006HK$37.95 B70.07%
2005HK$22.31 B24.95%
2004HK$17.86 B12.61%
2003HK$15.86 B9.67%
2002HK$14.46 B12.36%
2001HK$12.87 B11.04%
2000HK$11.59 B3.25%
1999HK$11.22 B20.27%
1998HK$9.33 B130.68%
1997HK$4.04 B91.79%
1996HK$2.11 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Universal Health Services
UHS
HK$132.79 B 27.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$107.57 B 3.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$162.97 B 56.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$15.02 B-85.57%๐Ÿ‡บ๐Ÿ‡ธ USA